CHA Comments on Stimulant Medication Shortages

CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.
Download

Children's Hospital Association and other children’s health groups submitted joint comments to the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) requesting the convening of stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

Our comments highlight the long-term negative impacts that children and their families may experience due to untreated attention deficit hyperactivity disorder and that these shortages exacerbate existing health disparities among families enrolled in Medicaid and CHIP.

Related Content

CHA Submits Comments in Response to Medicaid Provider Tax Proposed Rule

Provider taxes are important mechanisms used to fund programs and support providers that treat a large volume of Medicaid patients, including children’s hospitals.

July 15, 2025

The Pharmacy That Keeps Brynn Dancing

The Cincinnati Children’s home care pharmacy is indispensable to children with complex medical conditions.

July 10, 2025

Children’s Groups Submit Joint Comments on ACA Marketplace Affordability and Integrity Proposed Rule

Insurance coverage for children should ensure access to timely, affordable, high-quality, and age-appropriate health care that meets their unique needs.

July 08, 2025